Blood purine measurements as a rapid real-time indicator of reversible brain ischaemia.

Journal Information

Full Title: Purinergic Signal

Abbreviation: Purinergic Signal

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Biochemistry

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
2/6
0.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Disclosures FT and SB are employed by Sarissa Biomedical Ltd., the manufacturer of the biosensors used in the study and related in vitro diagnostic devices. ND is a Founder and Director of Sarissa Biomedical Ltd., and has equity in this company. Conflicts of interest Faming Tian is an employee of Sarissa Biomedical Ltd and is an inventor on patents that describe methods to measure purines and the use of purine measurements to diagnose ischaemia. Fakhra Bibi is an employee of Sarissa Biomedical Ltd. Nicholas Dale is a Director and Founder of Sarissa Biomedical Ltd, holds equity in that company and is an inventor on patents concerning the detection of purines and their use in diagnosis of ischaemia that are owned or licensed by Sarissa Biomedical. Christopher H. E. Imray is an inventor on patents that cover the use of purine measurements to diagnose ischaemia in a patient."

Evidence found in paper:

"University of Warwick"

Protocol Registration
Open Access
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025